Welcome to our dedicated page for Cellebrite Di news (Ticker: CLBTW), a resource for investors and traders seeking the latest updates and insights on Cellebrite Di stock.
The CLBTW news page on Stock Titan aggregates coverage related to Cellebrite DI Ltd., the underlying company for the CLBTW warrants. Cellebrite’s ordinary shares trade on Nasdaq under the symbol CLBT, and the company regularly issues press releases that are furnished to the SEC on Form 6-K. These announcements provide insight into its digital investigation and intelligence business, financial performance and strategic initiatives.
Readers can expect news about Cellebrite’s AI-powered Digital Investigation Platform, which the company says enables customers to lawfully access, collect, analyze and share digital evidence in legally sanctioned investigations while preserving data privacy. Coverage often highlights how thousands of public safety organizations, intelligence agencies and businesses use its digital forensic and investigative solutions across cloud, on-premises and hybrid deployments.
Company updates frequently include quarterly financial results, commentary on annual recurring revenue and subscription trends, and discussions of non-GAAP metrics and key performance indicators. Other news items describe product and platform developments, such as enhancements to its Guardian suite, Inseyets digital forensics software, Pathfinder investigative analytics and the Cellebrite Government Cloud, which is progressing through the FedRAMP process with U.S. Department of Justice sponsorship.
Strategic announcements have also covered the agreement to acquire, and subsequent completion of the acquisition of, Corellium, a provider of Arm-based virtualization software, along with integrations that expand mobile virtualization and device analysis capabilities. Additional stories highlight partnerships and initiatives like the integration of NCMEC’s CyberTipline hash value list into Inseyets to support child exploitation investigations, as well as events such as the C2C User Summit and Digital Justice Awards.
By following CLBTW-related news, investors and observers gain context on Cellebrite’s operational focus, technology roadmap, governance developments and regulatory milestones that may be relevant when evaluating the warrants linked to CLBT.
Cellebrite (Nasdaq: CLBT) announced a USD 2 million agreement with a national police force in EMEA to enhance its digital intelligence capabilities, deploying over 100 UFED end point licenses. This expansion marks one of the largest Cellebrite Premium Enterprise deployments, aimed at reducing case backlogs and improving investigative efficiency. Arthur Veinstein, General Manager of International Business, noted that this modernization effort will foster better collaboration among examiners and investigators.
Cellebrite (Nasdaq: CLBT) announced it will report Q1 2022 financial results on May 12, 2022, before market open. A conference call is scheduled for 8:30 AM ET to discuss the results. Cellebrite specializes in Digital Intelligence solutions, significantly aiding public and private sector investigations. The company aims to enhance data management processes for legally sanctioned investigations, establishing itself as a trusted provider globally.
Cellebrite (Nasdaq: CLBT) announced an expanded partnership with a major U.S. sheriff’s office, enhancing digital evidence capabilities for investigations into violent crimes and internet crimes against children. This multi-year agreement, generating revenue of approximately USD 700,000 since 2021, includes access to Cellebrite's comprehensive Digital Intelligence platform. Alon Klomek, Chief Business Officer, emphasized the importance of these solutions for law enforcement in speeding up investigations. The company remains committed to improving public safety through advanced technology.
Cellebrite, a leader in Digital Intelligence (DI) solutions, has secured a multi-year agreement valued at over USD $800,000 with a state department of public safety in the U.S. This partnership aims to enhance investigative capabilities for law enforcement agencies and drug task forces through advanced data extraction and analysis from digital devices. The agreement reinforces Cellebrite's commitment to aiding law enforcement in addressing narcotic and opioid-related crimes, ultimately contributing to community safety.
Cellebrite DI Ltd. (Nasdaq: CLBT) has appointed Dr. Guy Rotkopf, former Director General of the Israel Ministry of Justice, as the new Chairperson of its Ethics & Integrity Committee. This committee, established in 2021, guides the board on international law and ethical practices concerning the use of Cellebrite's technologies. Dr. Rotkopf holds a PH.D. in law and aims to enhance ethical standards in the company’s operations. The committee comprises eight members with diverse backgrounds in human rights and technology, reinforcing Cellebrite's dedication to responsible business practices.
Cellebrite (Nasdaq: CLBT) announced a multi-year agreement worth over $2.5 million with a national police agency in the Asia-Pacific region. This engagement will expand the deployment of Cellebrite’s Digital Intelligence (DI) solutions to assist in reducing crime and enhancing public safety. This contract extends their long-term relationship, reinforcing Cellebrite's reputation and impact in law enforcement. The deployment aims to support digital transformation within government agencies, bolstering safety measures through advanced investigative tools.
Cellebrite reported impressive financial results for 2021, achieving $246 million in revenue, a 26% year-over-year increase, and an Annual Recurring Revenue (ARR) of $187 million, up 37%. The company closed a record number of deals and launched new solutions to enhance digital intelligence. For 2022, Cellebrite forecasts 16-22% revenue growth and 34-42% ARR growth. CEO Yossi Carmil highlighted strong market positioning and commitment to innovation, aiming to maintain its leadership in the digital intelligence market.